Precision Wealth Strategies LLC Sells 6,249 Shares of Oscar Health, Inc. (NYSE:OSCR)

Precision Wealth Strategies LLC lessened its holdings in Oscar Health, Inc. (NYSE:OSCR) by 24.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,226 shares of the company’s stock after selling 6,249 shares during the quarter. Precision Wealth Strategies LLC’s holdings in Oscar Health were worth $408,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the business. Vanguard Group Inc. raised its holdings in Oscar Health by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock valued at $216,846,000 after buying an additional 337,850 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Oscar Health by 153.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after buying an additional 2,409,160 shares during the last quarter. Renaissance Technologies LLC raised its holdings in Oscar Health by 31.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after purchasing an additional 934,600 shares during the last quarter. First Light Asset Management LLC raised its holdings in Oscar Health by 117.3% during the 1st quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock worth $31,265,000 after purchasing an additional 1,134,919 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its holdings in Oscar Health by 32.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock worth $32,368,000 after purchasing an additional 507,009 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

Insider Transactions at Oscar Health

In related news, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the sale, the insider now owns 76,982 shares of the company’s stock, valued at approximately $1,384,906.18. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, CFO Richard Scott Blackley sold 68,978 shares of Oscar Health stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $1,240,914.22. Following the completion of the sale, the chief financial officer now owns 884,213 shares of the company’s stock, valued at approximately $15,906,991.87. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the sale, the insider now directly owns 76,982 shares of the company’s stock, valued at approximately $1,384,906.18. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 169,569 shares of company stock valued at $3,007,069 in the last quarter. 25.11% of the stock is currently owned by company insiders.

Oscar Health Stock Performance

Shares of OSCR stock opened at $15.96 on Tuesday. The company has a market cap of $3.86 billion, a price-to-earnings ratio of -122.76, a price-to-earnings-growth ratio of 34.83 and a beta of 1.62. Oscar Health, Inc. has a 52 week low of $4.72 and a 52 week high of $23.79. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.26. The firm has a 50 day moving average of $18.96 and a 200-day moving average of $18.32.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.16 by $0.04. The company had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.13 billion. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The company’s quarterly revenue was up 44.6% on a year-over-year basis. During the same quarter last year, the firm posted ($0.07) EPS. On average, equities analysts forecast that Oscar Health, Inc. will post 0.01 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on OSCR shares. Piper Sandler restated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a report on Tuesday, September 10th. UBS Group started coverage on shares of Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 price target for the company. Three equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $24.00.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.